WuXi AppTec is a global contract research organization (CRO) that offers a comprehensive range of preclinical development and testing services for the pharmaceutical and biotechnology industries. With facilities in China and the United States, they provide analytical, bioanalytical, DMPK (drug metabolism and pharmacokinetics), toxicology, and medical device services to support drug discovery and development.
Their expertise spans from early-stage research to IND-enabling studies, with capabilities in areas such as preclinical bioanalysis, safety assessment, genetic toxicology, and vaccine development. WuXi AppTec is committed to delivering high-quality solutions and has established itself as a trusted partner in the pharmaceutical industry.
Generated from the website